While every company is unique and the corporate initiatives that drive the equity capital-raising process are diverse, most Brinson Patrick clients share a desire to better manage the capital raising process through the control and flexibility we offer.

Two examples of our success include:

	REIT raises $82 million in a troubled market, with share price rising over 15% during the funding process.
	With an "approvable letter" from the FDA this biopharmaceutical company raised $16 million to fund clinical trials with virtually no impact on share price.

For a copy of these case studies or to discuss other client engagements that may better reflect your unique situation, please contact Brinson Patrick.